Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam
NCT00427505
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Deferasirox
Sponsor
Novartis